Emerald Mutual Fund Advisers Trust Acadia Pharmaceuticals Inc Transaction History
Emerald Mutual Fund Advisers Trust
- $1.45 Billion
- Q4 2024
A detailed history of Emerald Mutual Fund Advisers Trust transactions in Acadia Pharmaceuticals Inc stock. As of the latest transaction made, Emerald Mutual Fund Advisers Trust holds 500,391 shares of ACAD stock, worth $8.62 Million. This represents 0.63% of its overall portfolio holdings.
Number of Shares
500,391
Previous 574,810
12.95%
Holding current value
$8.62 Million
Previous $8.85 Million
3.8%
% of portfolio
0.63%
Previous 0.5%
Shares
13 transactions
Others Institutions Holding ACAD
# of Institutions
315Shares Held
164MCall Options Held
855KPut Options Held
350K-
Baker Bros. Advisors LP New York, NY42.9MShares$739 Million8.72% of portfolio
-
Vanguard Group Inc Valley Forge, PA13.9MShares$240 Million0.0% of portfolio
-
Black Rock Inc. New York, NY12.1MShares$208 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY8.71MShares$150 Million2.61% of portfolio
-
Morgan Stanley New York, NY7.3MShares$126 Million0.01% of portfolio
About ACADIA PHARMACEUTICALS INC
- Ticker ACAD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 161,843,008
- Market Cap $2.79B
- Description
- ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...